166 related articles for article (PubMed ID: 32068899)
1. LC-QToF-MS method for quantification of ethambutol, isoniazid, pyrazinamide and rifampicin in human plasma and its application.
Fachi MM; Vilhena RO; Boger B; Domingos EL; Dos Santos JMMF; Junkert AM; de Fátima Cobre A; Momade DRO; Beraldi-Magalhães F; de Liz MV; Cordeiro-Santos M; Pontarolo R
Biomed Chromatogr; 2020 May; 34(5):e4812. PubMed ID: 32068899
[TBL] [Abstract][Full Text] [Related]
2. Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
Wu L; Ye Z; Liu H; Guo H; Lin J; Zheng L; Chu N; Liu X
J Pharm Biomed Anal; 2020 Feb; 180():113076. PubMed ID: 31896523
[TBL] [Abstract][Full Text] [Related]
3. LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
Kivrane A; Grinberga S; Sevostjanovs E; Igumnova V; Pole I; Viksna A; Bandere D; Krams A; Cirule A; Pugovics O; Ranka R
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122986. PubMed ID: 34688197
[TBL] [Abstract][Full Text] [Related]
4. Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring.
Gao S; Wang Z; Xie X; You C; Yang Y; Xi Y; Chen W
Tuberculosis (Edinb); 2018 Mar; 109():28-34. PubMed ID: 29559118
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
Prahl JB; Lundqvist M; Bahl JM; Johansen IS; Andersen ÅB; Frimodt-Møller N; Cohen AS
APMIS; 2016 Nov; 124(11):1004-1015. PubMed ID: 27546025
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma.
Zhou Z; Wu X; Wei Q; Liu Y; Liu P; Ma A; Zou F
Anal Bioanal Chem; 2013 Jul; 405(19):6323-35. PubMed ID: 23719934
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry.
Song SH; Jun SH; Park KU; Yoon Y; Lee JH; Kim JQ; Song J
Rapid Commun Mass Spectrom; 2007; 21(7):1331-8. PubMed ID: 17340570
[TBL] [Abstract][Full Text] [Related]
8. Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.
Xu J; Jin H; Zhu H; Zheng M; Wang B; Liu C; Chen M; Zhou L; Zhao W; Fu L; Lu Y
Clin Ther; 2013 Feb; 35(2):161-8. PubMed ID: 23410999
[TBL] [Abstract][Full Text] [Related]
9. A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of isoniazid and ethambutol in human plasma.
Chen X; Song B; Jiang H; Yu K; Zhong D
Rapid Commun Mass Spectrom; 2005; 19(18):2591-6. PubMed ID: 16106359
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma.
Zheng X; Jongedijk EM; Hu Y; Kuhlin J; Zheng R; Niward K; Paues J; Xu B; Davies Forsman L; Schön T; Bruchfeld J; Alffenaar JC
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1158():122397. PubMed ID: 33091676
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
[TBL] [Abstract][Full Text] [Related]
12. A rapid and robust liquid chromatography/tandem mass spectrometry method for simultaneous analysis of anti-tuberculosis drugs--ethambutol and pyrazinamide in human plasma.
Gong Z; Basir Y; Chu D; McCort-Tipton M
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(16-17):1698-704. PubMed ID: 19419912
[TBL] [Abstract][Full Text] [Related]
13. Determinants of serum concentration of first-line anti-tuberculosis drugs from China.
Lei Q; Wang H; Zhao Y; Dang L; Zhu C; Lv X; Wang H; Zhou J
Medicine (Baltimore); 2019 Oct; 98(41):e17523. PubMed ID: 31593125
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi.
van Oosterhout JJ; Dzinjalamala FK; Dimba A; Waterhouse D; Davies G; Zijlstra EE; Molyneux ME; Molyneux EM; Ward S
Antimicrob Agents Chemother; 2015 Oct; 59(10):6175-80. PubMed ID: 26248378
[TBL] [Abstract][Full Text] [Related]
15. Quantification of pyrazinamide, isoniazid, acetyl-isoniazid, and rifampicin by a high-performance liquid chromatography method in human plasma from patients with tuberculosis.
Hernández-González O; Zarazúa S; Veytia-Bucheli JI; González-Chávez MM; Rodríguez-Pinal CJ; Medellín-Garibay SE; Uresti-Rivera EE; Pérez-Vázquez FJ; Portales-Pérez DP; Romano-Moreno S; Milán-Segovia RDC
J Sep Sci; 2021 Jan; 44(2):521-529. PubMed ID: 33200497
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of liquid chromatography tandem mass spectrometry method for simultaneous quantification of first line tuberculosis drugs and metabolites in human plasma and its application in clinical study.
Hee KH; Seo JJ; Lee LS
J Pharm Biomed Anal; 2015 Jan; 102():253-60. PubMed ID: 25459921
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of isoniazid, pyrazinamide, rifampicin and acetylisoniazid in human plasma by high-performance liquid chromatography.
Zhou Z; Chen L; Liu P; Shen M; Zou F
Anal Sci; 2010; 26(11):1133-8. PubMed ID: 21079341
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.
Bekker A; Schaaf HS; Draper HR; van der Laan L; Murray S; Wiesner L; Donald PR; McIlleron HM; Hesseling AC
Antimicrob Agents Chemother; 2016 Apr; 60(4):2171-9. PubMed ID: 26810651
[TBL] [Abstract][Full Text] [Related]
19. Determination of rifampicin, isoniazid and pyrazinamide by high performance liquid chromatography after their simultaneous extraction from plasma.
Smith PJ; van Dyk J; Fredericks A
Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S325-8; discussion S351-2. PubMed ID: 10593712
[TBL] [Abstract][Full Text] [Related]
20. Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
Herrera-Pérez IG; Rodríguez-Báez AS; Ortiz-Álvarez A; Velarde-Salcedo R; Arriaga-García FJ; Rodríguez-Pinal CJ; Romano-Moreno S; Milán-Segovia RDC; Medellín-Garibay SE
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123801. PubMed ID: 37453389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
